Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JAMA Oncology is Scopus-indexed (Q1, CiteScore 32.6), WoS SCIE. Published by American Medical Association.
Checked against the index lists dated .
ISSN 2374-2437Verify ISSN ↗2374-2445Verify ISSN ↗
Publisher: American Medical Association
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 12 / 428 | 97th | Q1 |
| Cancer Research | 9 / 233 | 96th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q1, CiteScore 32.6.
JAMA Oncology is Q1 in Oncology (rank 12 of 428) and Q1 in Cancer Research (rank 9 of 233), by CiteScore 2025.
JAMA Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 32.6, which places it in quartile Q1 at the 97th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 7.399, quartile Q1, with an H-index of 208.
JAMA Oncology is published by American Medical Association. Its print ISSN is 2374-2437 and its online ISSN is 2374-2445.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
JAMA Oncology has an h-index of 248 and a 2-year mean of 8.3 citations per paper (OpenAlex). Its Scopus CiteScore is 32.6, quartile Q1. On 2-year citations it ranks #23 of 424 Scopus journals in Oncology.
JAMA Oncology published 337 papers in 2025; its busiest recent year was 2018 with 491. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 87 research articles (2026), authors are most often from United States (42.7%), China (20.1%) and Canada (4.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.